A clinical trial tested using focused ultrasound to perform a capsulotomy in participants with obsessive-compulsive disorder (OCD) and major depressive disorder (MDD).
Long-term results now show that the treatment is safe in patients with OCD and MDD and particularly effective for OCD.
For more than 20 years, Shenzhen PRO HITU Medical Co., LTD. has built ultrasound-guided focused ultrasound systems to treat uterine fibroids, placenta implantation, chronic pelvic pain, and more.
We spoke with CEO George Zhang about its vision and what comes next for the company.
In this blog post, Cindy Clark answers the most common questions companies have about pursuing funding from the Advanced Research Projects Agency for Health (ARPA-H).
Learn more about an upcoming “Doing Business with ARPA-H Industry Day” on November 13.
The Foundation’s Research Awards Program recently initiated nine preclinical projects that use focused ultrasound to treat neuropathic pain, pancreatic cancer, dementia, Alzheimer’s disease, and more.